Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Surgery Partners (SGRY) Net Margin (2016 - 2025)

Surgery Partners' Net Margin history spans 12 years, with the latest figure at 3.28% for Q4 2025.

  • For Q4 2025, Net Margin rose 867.0% year-over-year to 3.28%; the TTM value through Dec 2025 reached 2.99%, up 259.0%, while the annual FY2025 figure was 2.99%, 259.0% up from the prior year.
  • Net Margin for Q4 2025 was 3.28% at Surgery Partners, up from 3.08% in the prior quarter.
  • Across five years, Net Margin topped out at 8.64% in Q2 2023 and bottomed at 6.11% in Q1 2021.
  • The 5-year median for Net Margin is 0.51% (2023), against an average of 0.52%.
  • The largest annual shift saw Net Margin soared 1163bps in 2023 before it crashed -1174bps in 2024.
  • A 5-year view of Net Margin shows it stood at 0.02% in 2021, then plummeted by -20093bps to 3.31% in 2022, then soared by 292bps to 6.35% in 2023, then plummeted by -185bps to 5.39% in 2024, then skyrocketed by 161bps to 3.28% in 2025.
  • Per Business Quant, the three most recent readings for SGRY's Net Margin are 3.28% (Q4 2025), 3.08% (Q3 2025), and 5.43% (Q2 2025).